Skip to main content
GlaxoSmithKline PLC logo

GlaxoSmithKline PLC — Investor Relations & Filings

Ticker · GSK ISIN · GB00BN7SWP63 LEI · 5493000HZTVUYLO1D793 IL Manufacturing
Open in API
Filings indexed 7,016 across all filing types
Latest filing 2025-10-24 Regulatory Filings
Country GB United Kingdom
Listing IL GSK

About GlaxoSmithKline PLC

https://www.gsk.com/en-gb/

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.

Recent filings

Filing Released Lang Actions
Blenrep approved by US FDA in multiple myeloma
Regulatory Filings Classification · 100% confidence The document is a press release from GSK PLC announcing the US FDA approval of a drug (Blenrep). It follows the standard format of a corporate regulatory announcement (RNS), detailing clinical trial results, regulatory status, and contact information for media and investor relations. It is not a financial report, but rather a corporate news announcement regarding product development and regulatory milestones.
2025-10-24 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from GSK plc regarding the purchase of its own shares (share buyback) on the London Stock Exchange. It includes specific details such as the date of purchase, number of shares, price paid, and the resulting impact on treasury shares and total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-10-24 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2025-10-23 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from GSK plc regarding the purchase of its own shares (share buyback). It details the date of purchase, the number of shares acquired, price information, and the resulting impact on treasury shares and total voting rights. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-10-23 English
POSITIVE DATA FOR LOW CARBON VERSION VENTOLIN MDI
Regulatory Filings
2025-10-22 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2025-10-22 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.